It was revealed that RBCs from severe COVID-19 patients displayed signatures of oxidation and fragmentation of key structural and functional proteins including band 3 (AE1), spectrin beta and ankyrin, as well as revealing increased glycolytic intermediates, including 2,3-DPG, without significant changes in ATP levels [16]. The gene discussed is SLC4A1; the disease is COVID-19.